1.
Orban, E, Schwab, S, Thorand, B, et al. (2014) Association of iron indices and type 2 diabetes: a meta-analysis of observational studies. Diabetes Metab Res Rev
30, 372–394.
2.
Bao, W, Rong, Y, Rong, S, et al. (2012) Dietary iron intake, body iron stores, and the risk of T2D: a systematic review and meta-analysis. BMC Med
10, 119.
3.
Lapice, E, Masulli, M & Vaccaro, O (2013) Iron deficiency and cardiovascular disease: an updated review of the evidence. Curr Atheroscler Rep
15, 358.
4.
Abril-Ulloa, V, Flores-Mateo, G, Solà-Alberich, R, et al. (2014) Ferritin levels and risk of metabolic syndrome: meta-analysis of observational studies. BMC Public Health
21, 483.
5.
Fernandez-Real, JM, Lopez-Bermejo, A & Ricart, W (2002) Cross-talk between iron metabolism and diabetes. Diabetes
51, 2348–2354.
6.
Zhao, Z, Li, S, Liu, G, et al. (2012) Body iron stores and heme-iron intake in relation to risk of T2D: a systematic review and meta-analysis. PLOS ONE
l, 7.
7.
Aisen, P, Wessling-Resnick, M & Leibold, EA (1999) Iron metabolism. Curr Opin Chem Biol
3, 200–206.
8.
Trinder, D & Baker, E (2003) Transferrin receptor 2: a new molecule in iron metabolism. Int J Biochem Cell Biol
35, 292–296.
9.
Ganz, T & Nemeth, E (2006) Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol
290, G199–G203.
10.
Cook, JD, Skikne, BS & Baynes, RD (1993) Serum transferrin receptor. Annu Rev Med
44, 63–74.
11.
Kæstel, P, Aaby, P, Ritz, C, et al. (2015) Markers of iron status are associated with stage of pregnancy and acute-phase response, but not with parity among pregnant women in Guinea-Bissau. Br J Nutr
114, 1072–1079.
12.
Hamalainen, P, Saltevo, J, Kautiainen, H, et al. (2012) Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study. Cardiovas Diabetol
11, 116.
13.
Montonen, J, Boeing, H, Steffen, A, et al. (2012) Body iron stores and risk of T2D: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia
55, 2613–2621.
14.
Aderibigbe, OR, Pisa, PT, Mamabolo, RL, et al. (2011) Iron status and cardiovascular disease risk in black South African women: the PURE study. S Afr J Clin Nutr
24, 179–185.
15.
Vitart, V, Rudan, I, Hayward, C, et al. (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet
40, 437–442.
16.
Polasek, O (2013) Future of biobanks – bigger, longer, and more dimensional. Croat Med J
54, 496–500.
17.
Rudan, I, Marusić, A, Janković, S, et al. (2009) ‘10001 Dalmatians’: Croatia launches its national biobank.
Croat Med J
50, 4–6.
18.
Matthews, DR, Hosker, JP, Rudenski, AS, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia
28, 412–419.
19.
Alberti, KG, Eckel, RH, Grundy, SM, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation
120, 1640–1645.
20.
Bardini, G, Dicembrini, I, Cresci, B, et al. (2010) Inflammation markers and metabolic characteristics of subjects with 1-h plasma glucose levels. Diabetes Care
33, 411–413.
21.
Temelkova-Kurktschiev, T, Siegert, G, Bergmann, S, et al. (2002) Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism
51, 743–749.
22.
Leiva, E, Mujica, V, Sepúlveda, P, et al. (2013) High levels of iron status and oxidative stress in patients with metabolic syndrome. Biol Trace Elem Res J
151, 1–8.
23.
Fernández-Real, JM, Moreno, JM, López-Bermejo, A, et al. (2007) Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity. Diabetes Care
30, 604–608.
24.
Huth, C, Beuerle, S, Zierer, A, et al. (2015) Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study. Eur J Endocrinol
173, 643–653.
25.
Arija, V, Fernández-Cao, JC, Basora, J, et al. (2014) Excess body iron and the risk of type 2 diabetes mellitus: a nested case-control in the PREDIMED (PREvention with MEDiterranean Diet) study. Br J Nutr
112, 1896–1904.
26.
Fernández-Real, JM, Izquierdo, M, Moreno-Navarrete, JM, et al. (2009) Circulating soluble transferrin receptor concentration decreases after exercise-induced improvement of insulin sensitivity in obese individuals.
Int J Obes (Lond)
33, 768–774.
27.
Fernández-Real, JM, Mercader, JM, Ortega, FJ, et al. (2010) Transferrin receptor-1 gene polymorphisms are associated with type 2 diabetes. Eur J Clin Invest
40, 600–607.
28.
Morris, AP, Voight, BF, Teslovich, TM, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet
44, 981–990.
29.
He, M, Workalemahu, T, Manson, JE, et al. (2012) Genetic determinants for body iron store and type 2 diabetes risk in US men and women. PLOS ONE
7, e40919.
30.
Ratajczak, J, Zhang, Q, Pertusini, E, et al. (1998) The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions – comparison to other cytokines and growth factors. Leukemia
12, 371–381.
31.
Beguin, Y (2003) Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta
329, 9–22.
32.
Biswas, S, Tapryal, N, Mukherjee, R, et al. (2013) Insulin promotes iron uptake in human hepatic cell by regulating transferrin receptor-1 transcription mediated by hypoxia inducible factor-1. Biochim Biophys Acta
1832, 293–301.
33.
Cho, GJ, Shin, JH, Yi, KW, et al. (2011) Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
Menopause
18, 1120–1124.
34.
Yoon, JH, Linton, JA, Koh, SB, et al. (2012) Serum ferritin concentrations predict incidence of metabolic syndrome in rural Korean adults. Clin Chem Lab Med
50, 2057–2059.
35.
Jehn, M, Clark, JM & Guallar, E (2004) Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes care
27, 2422–2428.
36.
Vari, IS, Balkau, B, Kettaneh, A, et al. (2007) Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care
30, 1795–1801.
37.
Lee, BK, Kim, Y & Kim, YI (2011) Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008. Metabolism
60, 1416–1424.
38.
Yoo, KD, Ko, SH, Park, JE, et al. (2012) High serum ferritin levels are associated with metabolic risk factors in non-obese Korean young adults: Korean National Health and Nutrition Examination Survey (KNHANES) IV.
Clin Endocrinol (Oxf)
77, 233–240.
39.
Cheung, CL, Cheung, TT, Lam, KS, et al. (2013) High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of US adults. Clin Nutr
32, 1055–1060.
40.
Rajpathak, SN, Wylie-Rosett, J, Gunter, MJ, et al. (2009) Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab
11, 472–479.
41.
Meigs, JB (2008) The role of obesity in insulin resistance. In The Metabolic Syndrome: Epidemiology, Clinical Treatment, and Underlying Mechanisms, pp. 37–55 [BC Hansen & GA Bray, editors]. Totowa, NJ: Humana Press, a part of Springer Science & Business Media.
42.
Tang, Q, Liu, Z, Tang, Y, et al. (2015) High serum ferritin level is an independent risk factor for metabolic syndrome in a Chinese male cohort population. Diabetol Metab Syndr
7, 11.
